Fulgent Genetics Faces Securities Fraud Investigation

New Investigation: Kirby McInerney LLP is examining whether Fulgent Genetics&#x27; senior management engaged in <strong class="body_output text-content_primary font-semibold" node="[object Object]">unlawful business practices or securities fraud .
Trigger Event: The investigation was initiated following a press release from Fulgent on <strong class="body_output text-content_primary font-semibold" node="[object Object]">February 27, 2026 , which detailed its fourth quarter and full-year financial results.
Investor Risk: The probe exposes Fulgent to potential legal penalties and reputational damage, creating significant <strong class="body_output text-content_primary font-semibold" node="[object Object]">downside risk for its stock price (FLGT) .

Law Firm Launches Probe Into Fulgent on March 17

The law firm Kirby McInerney LLP announced on March 17, 2026, that it has opened an investigation into potential claims against Fulgent Genetics Inc. (NASDAQ: FLGT). The inquiry centers on whether the genetic testing company or its senior executives may have violated federal securities laws or participated in other illegal business activities. This development places Fulgent's corporate governance and financial reporting under direct legal scrutiny, creating uncertainty for shareholders.

Financial Report on Feb. 27 Precedes Investigation

The investigation was prompted by Fulgent's press release on February 27, 2026, which reported its fourth quarter and full-year financial results for 2025. While the specific details of the allegations are not yet public, the timing suggests the firm's financial disclosures are a central component of the probe. For investors, such an investigation can signal underlying issues with a company's reporting standards or business operations. A formal lawsuit could result in substantial legal costs, financial penalties, and lasting reputational damage, potentially causing a significant decline in investor confidence and the company's stock value.